Phase 2 Study: A Double-blind, Randomised, Clinical Cross-over Trial to Investigate the Treatment Potential of Liraglutide Compared to Glimepiride in MODY Patients [Effekten af GLP-1 i maturity onset diabetes of the young (MODY)]
Phase of Trial: Phase II
Latest Information Update: 07 Sep 2013
At a glance
- Drugs Liraglutide (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms MODY
- 23 Aug 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 14 Jan 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 11 Aug 2012 Actual initiation date (3 Aug 2012) added as reported by European Clinical Trials Database.